NO771023L - Fremgangsm}te for fremstilling av cefalosporiner. - Google Patents

Fremgangsm}te for fremstilling av cefalosporiner.

Info

Publication number
NO771023L
NO771023L NO771023A NO771023A NO771023L NO 771023 L NO771023 L NO 771023L NO 771023 A NO771023 A NO 771023A NO 771023 A NO771023 A NO 771023A NO 771023 L NO771023 L NO 771023L
Authority
NO
Norway
Prior art keywords
cephalosporine
procedure
preparation
Prior art date
Application number
NO771023A
Other languages
English (en)
Other versions
NO158505C (no
NO158505B (no
Inventor
Masayuki Narisada
Wataru Nagata
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO771023L publication Critical patent/NO771023L/no
Publication of NO158505B publication Critical patent/NO158505B/no
Publication of NO158505C publication Critical patent/NO158505C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO771023A 1976-03-25 1977-03-23 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 7beta-substituert malonamido-1-oksadetia 7alfa-metoksy-3-(1-metyltetrazol-5-yl)-tiometyl cefalosporin. NO158505C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics

Publications (3)

Publication Number Publication Date
NO771023L true NO771023L (no) 1977-09-27
NO158505B NO158505B (no) 1988-06-13
NO158505C NO158505C (no) 1988-09-21

Family

ID=26372085

Family Applications (2)

Application Number Title Priority Date Filing Date
NO771023A NO158505C (no) 1976-03-25 1977-03-23 Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 7beta-substituert malonamido-1-oksadetia 7alfa-metoksy-3-(1-metyltetrazol-5-yl)-tiometyl cefalosporin.
NO862107A NO862107L (no) 1976-03-25 1986-05-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporin-derivater.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO862107A NO862107L (no) 1976-03-25 1986-05-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporin-derivater.

Country Status (19)

Country Link
AR (1) AR224606A1 (no)
BG (1) BG31074A3 (no)
CY (1) CY1158A (no)
DD (1) DD129792A5 (no)
DE (1) DE2713370C2 (no)
DK (1) DK161331C (no)
ES (5) ES457174A1 (no)
GR (1) GR61146B (no)
HK (1) HK46882A (no)
HU (1) HU172720B (no)
IE (1) IE44794B1 (no)
IL (1) IL51743A (no)
MX (1) MX4348E (no)
NO (2) NO158505C (no)
NZ (1) NZ183687A (no)
PT (1) PT66346B (no)
RO (2) RO78228A (no)
SE (1) SE443143B (no)
YU (2) YU44038B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU514377B2 (en) * 1977-02-15 1981-02-05 Shionogi & Co., Ltd. l-OXADETHIACEPHAM COMPOUNDS
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US3962232A (en) * 1973-11-05 1976-06-08 Eli Lilly And Company 7-methoxycephalosporins
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
BG31074A3 (en) 1981-10-15
ES469284A1 (es) 1978-11-16
ES469286A1 (es) 1979-09-16
HK46882A (en) 1982-11-19
DK131277A (da) 1977-09-26
YU44038B (en) 1990-02-28
ES469285A1 (es) 1979-09-16
IL51743A (en) 1980-10-26
DK161331B (da) 1991-06-24
GR61146B (en) 1978-09-27
NZ183687A (en) 1979-01-11
ES469287A1 (es) 1979-09-16
SE443143B (sv) 1986-02-17
NO158505C (no) 1988-09-21
RO71742A (ro) 1982-02-26
IE44794L (en) 1977-09-25
HU172720B (hu) 1978-11-28
CY1158A (en) 1983-01-28
PT66346B (en) 1978-08-16
NO158505B (no) 1988-06-13
YU44039B (en) 1990-02-28
DE2713370C2 (de) 1994-04-21
DD129792A5 (de) 1978-02-08
YU173783A (en) 1983-12-31
ES457174A1 (es) 1978-08-16
AR224606A1 (es) 1981-12-30
NO862107L (no) 1977-09-27
DE2713370A1 (de) 1977-09-29
RO78228A (ro) 1982-02-01
IE44794B1 (en) 1982-04-07
PT66346A (en) 1977-04-01
MX4348E (es) 1982-04-05
YU173883A (en) 1983-12-31
SE7703325L (sv) 1977-09-26
DK161331C (da) 1991-12-09

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO772085L (no) Fremgangsm}te for fremstilling av antibakterielle forbindelser
NO147386C (no) Fremgangsmaate for fremstilling av forbedrete bitumer/polymerblandinger.
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
NO770366L (no) Fremgangsm}te for fremstilling av meta-aryloksy-benzaldehyder.
NO771277L (no) Fremgangsm}te for fremstilling av aromatiske uretaner
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO770183L (no) Fremgangsm}te for fremstilling av heksanitrostilben.
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NO771159L (no) Fremgangsm}te ved fremstilling av titantetraklorid.
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE433081B (sv) Forfarande for framstellning av cefalosporinforeningar
NO772960L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO771870L (no) Fremgangsm}te for fremstilling av 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE432765B (sv) Forfarande for framstellning av 2,9-dioxatricyklo/4,3,1,0?723?72,?727/dekaner
NO770673L (no) Fremgangsm}te for fremstilling av benzylestere.
NO772809L (no) Fremgangsm}te for fremstilling av 2,6-diterti{rt-butylfenol
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler